Assist. Prof. Dr. Fulya Erendor Cihan | Medicine and Health Sciences | Best Review Paper Award
Ordu University | Turkey
Dr. Fulya Erendor Cihan is an emerging researcher in gene and cell therapy, with a strong focus on precision gene editing, viral vector systems, and therapeutic strategies for metabolic and neurodegenerative diseases. Her work integrates advanced molecular biology techniques with translational research, particularly in diabetes, COVID-19 vaccine development, and neuroprotection. She has contributed to multiple nationally funded research projects and international collaborations, emphasizing lentiviral and adenoviral vector-based therapies. Her research outputs include high-impact journal publications, conference proceedings, and book chapters, reflecting her growing influence in biomedical innovation and experimental therapeutics.
300
250
200
150
100
50
0
150
25
5
Citations
Documents
h-index
View Google Scholar Profile View ORCID Profile
Featured Publications
Advancing CRISPR genome editing into gene therapy clinical trials: progress and future prospects
– Expert Reviews in Molecular Medicine, 2025 | Cited by: 55
Gene and cell therapy of human genetic diseases: Recent advances and future directions
– Journal of Cellular and Molecular Medicine, 2024 | Cited by: 33
Lentivirus mediated pancreatic beta-cell-specific insulin gene therapy for STZ-induced diabetes
– Molecular Therapy, 2021 | Cited by: 30
Lentiviral gene therapy vectors encoding VIP suppressed diabetes-related inflammation and augmented pancreatic beta-cell proliferation
– Gene Therapy, 2021 | Cited by: 21
Microglia cells treated with synthetic vasoactive intestinal peptide or transduced with LentiVIP protect neuronal cells against degeneration
– European Journal of Neuroscience, 2024 | Cited by: 6
